In a paper published in Scientific Reports scientists from LSTM’s Research Centre for Drugs and Diagnostics (RCDD) have described a new way of screening potential treatments for Tuberculosis (TB)  which may assist in the identification and prioritisation of new therapies which could potentially reduce the duration of current TB treatment